Stocks making the biggest moves midday: Nike, Rent-A-Center, Carnival Cruise


People walk near the entrance to Nike store, May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Check out the companies making headlines in midday trading.

Nike — Nike shares dropped 12.8% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its latest quarter. As a result it will offer more discounts to clear out the excess merchandise. Other retailers were also dragged down, with Lululemon Athletica and Under Armour losing almost 6% and nearly 5% respectively.

Rent-A-Center — Shares of Rent-A-Center slipped 21.6% after the company slashed its current-quarter earnings guidance, saying that economic conditions have weighed on consumer traffic and payment patterns.

Carnival Cruise — Shares of Carnival Cruise plunged 23.3% after the company forecast a loss for the fourth quarter, saying high fuel prices and inflation will delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also slipped, falling 13% and 18%, respectively.

Micron — Shares of Micron rose 1.7% after the company reported quarterly earnings that beat Wall Street expectations, even though sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are being hit by slowing consumer demand.

Charles River Laboratories — Charles River shares rose 3.6% after Jefferies upgraded the stock to buy from hold, citing the company’s potential in animal studies.

Twitter — Shares of Twitter rose 2.6% after texts between its founder, Jack Dorsey, and Elon Musk were released in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor — Shares of steel company Nucor jumped 1.6% after it announced plans to spend $425 million expanding a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals — Shares of the pharmaceutical company dropped 6.8% despite the stock rallying after hours Thursday on news of the Food and Drug Administration approving its controversial Lou Gehrig’s disease drug.

Generac — Shares of Generac gained 2.3% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear industry winner and has value in its solar offering.

— CNBC’s Alex Harring and Michelle Fox contributed reporting.



Source link

Related articles

Optimism Releases Required Op Batcher V1 17 0 Improve

Trusted Editorial content material, reviewed by main trade consultants and seasoned editors. Advert Disclosure TL;DR Optimism has launched op-batcher v1.17.0. The undertaking labels it a required improve for batcher operators. It provides Glamsterdam compatibility, safety updates and...

Why Is Ethereum Up In the present day? ETH Hits Highest Value Since January as $2,757 Comes Into View

Ethereum is up once more at this time (Saturday), extending Friday's rally to its highest value since January. Ether traded at $2,646 on Bitstamp at 17:56 UTC, up 1.3% on the day and...

Flock reportedly tries to shrink workforce with worker buyouts

Embattled surveillance know-how firm Flock Security unveiled a “beneficiant” severance package deal for voluntary worker departures on Friday, in keeping with a report in Wired. Flock reportedly expects a good portion of its 1,500-person...

EU Cyber Resilience Act Brings 24-Hour Vulnerability Reporting Into Power

TL;DR Components of the EU Cyber Resilience Act’s vulnerability-reporting regime are actually relevant. Producers should concern early warnings for actively exploited vulnerabilities inside 24 hours. Industrial crypto wallets can fall throughout the broader class of merchandise...

Trump says he’ll appoint an AI czar and type an "AI Pressure", in a Reality Social put up that rejects AI security issues as...

María Paula Mijares Torres / Bloomberg: Trump says he'll appoint an AI czar and type an “AI Pressure”, in a Reality Social put up that rejects AI security issues as a “hoax”  — ...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com